Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- None.
- None.
The options have an exercise price of
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301890877.html
SOURCE Akebia Therapeutics
FAQ
What is the purpose of Akebia Therapeutics, Inc. granting stock options to Ellen Snow?
How many shares of Akebia's common stock did Ellen Snow receive options to purchase?
What is the exercise price of the stock options granted to Ellen Snow?